More funding support for Victorian medical researchers

Grants have been awarded to 14 projects across 9 institutions.

Recipients will share $3 million in funding to develop the next generation of life-saving treatments.

The VMRAF fast-tracks early-stage research into real-world, life-saving treatments.

One project from Monash University has received $500,000 to integrate AI into breast screening programs to help detect heart disease risk in women earlier.

Peter MacCallum Cancer Centre has received $500,000 to explore a new personalised treatment for stomach cancer. It uses the DNA of patients’ tumours to target chemotherapy where it is most effective.

WEHI has received $500,000 to lead a clinical trial at three hospitals. The trial will evaluate a new treatment for acute myeloid leukaemia, a cancer that affects blood and bone marrow. Victorian biotech company Aculeus Therapeutics developed the treatment.

Austin Health has received $100,000 to assess a new, non-invasive way to test kidney function. This is part of its work to develop new treatments and run clinical trials in diabetic kidney disease.

Under the VMRAF, over $25 million in grants has supported 136 projects.This has helped fast-track results so new treatments reach Victorian patients sooner.

For the full list of recipients, visit the Victorian Medical Research Acceleration Fund.